Chemotherapy delay after primary debulking surgery for ovarian cancer

详细信息    查看全文

• 作者：Brandon-Luke L. Seaglep> ; p>p>brandon.seagle@northwestern.edup> ; Sharlay K. Butler ; Anna E. Strohl ; Wilberto Nieves-Neira ; Shohreh Shahabi
• 关键词：Ovarian cancer ; Survival ; Chemotherapy ; Treatment Delay ; Prognosis
• 刊名：Gynecologic Oncology
• 出版年：2017
• 出版时间：February 2017
• 年：2017
• 卷：144
• 期：2
• 页码：260-265
• 全文大小：367 K
• 卷排序：144

文摘

Nearly 60% of women experience chemotherapy delay > 28 days. Chemotherapy delay > 35 days is associated with a 7% increased hazard of death. The evidence-based best surgery to chemotherapy interval is 21–35 days.